RobertMarshallNeerMDPhD, FACP
Internal Medicine • Boston, MAEndocrinology
Director, Osteoporosis Center, Massachusetts General Hospital
Dr. Neer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit Street Bul 327
Endocrine Associates
Boston, MA 02114Phone+1 617-726-6723Fax+1 617-724-2718
Education & Training
Massachusetts General HospitalResidency, Internal Medicine, 1966 - 1969
Yale-New Haven Medical CenterResidency, Internal Medicine, 1965 - 1966
Clinical Center at the National Institutes of HealthResidency, Internal Medicine, 1963 - 1965
Jacobi Medical Center/Albert Einstein College of MedicineResidency, Internal Medicine, 1961 - 1963
Columbia University Vagelos College of Physicians and SurgeonsClass of 1961
Certifications & Licensure
MA State Medical License 1968 - 2015
Clinical Trials
- Alendronate and/or Parathyroid Hormone for Osteoporosis Start of enrollment: 1999 Aug 01
- Parathyroid Hormone (PTH) for Osteoporosis in Postmenopausal Women Start of enrollment: 2004 May 01
- Denosumab, Teriparatide or Both for the Treatment of Postmenopausal Osteoporosis Start of enrollment: 2009 Jun 01
Publications & Presentations
PubMed
- 47 citationsAntimullerian Hormone and Impending Menopause in Late Reproductive Age: The Study of Women's Health Across the Nation.Joel S. Finkelstein, Hang Lee, Arun S. Karlamangla, Robert M. Neer, Patrick M. Sluss
The Journal of Clinical Endocrinology and Metabolism. 2020-04-01 - 4 citationsLetter to the editor in response to the commentary, "Concurrent administration of PTH and antiresorptives: Additive effects or DXA cosmetics.Benjamin Z. Leder, Joy N. Tsai, Sherri-Anne Burnett-Bowie, Mary L. Bouxsein, Robert M. Neer
Bone. 2016-08-01 - 22 citationsResponse to Therapy With Teriparatide, Denosumab, or Both in Postmenopausal Women in the DATA (Denosumab and Teriparatide Administration) Study Randomized Controlled T...Benjamin Z. Leder, Joy N. Tsai, Robert M. Neer, Alexander V. Uihlein, Paul M. Wallace
Journal of Clinical Densitometry. 2016-07-01
Press Mentions
Longitudinal Assessment of Physical Activity and Cognitive Outcomes Among Women at MidlifeMarch 31st, 2021- Menopausal Vasomotor Symptoms and Risk of Incident Cardiovascular Disease Events in SWANJanuary 20th, 2021
Association Between Coarse Particulate Matter and Inflammatory and Hemostatic Markers in a Cohort of Midlife WomenNovember 5th, 2020- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
